Hc Biopharma Inc.
Clinical trials sponsored by Hc Biopharma Inc., explained in plain language.
-
New drug combo targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called HC010 combined with chemotherapy in people with advanced solid tumors that have spread or cannot be removed. The main goal is to find a safe dose and check for side effects. About 331 participants will join, and researchers will also…
Phase: PHASE1 • Sponsor: HC Biopharma Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug combo aims to control advanced lung cancer
Disease control Recruiting nowThis early-stage trial tests a new drug called HC010 combined with chemotherapy in people with advanced lung cancer that has spread or come back. The main goal is to find a safe dose and check for side effects. About 328 adults will take part, and researchers will also see if the…
Phase: PHASE1 • Sponsor: HC Biopharma Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New hope for lung cancer: experimental drug HC010 enters phase 2 trial
Disease control Recruiting nowThis study tests a new drug called HC010 in people with advanced non-small cell lung cancer that has a specific marker (PD-L1). The goal is to see if the drug can shrink tumors and control the disease. About 50 participants will receive the treatment, and researchers will monitor…
Phase: PHASE2 • Sponsor: HC Biopharma Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC